Healthy Participants Clinical Trial
Official title:
The Effects of Resistance Training With Hydrolyzed Collagen Supplementation on Muscle and Tendon Adaptation in Healthy Young Adults
Verified date | February 2024 |
Source | Liverpool John Moores University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to investigate the effects of resistance training with hydrolyzed collagen ingestion on changes in muscle and tendon adaptation in healthy young men and women. The main questions it aims to answer are: - Does resistance training with hydrolyzed collagen ingestion lead to greater changes in tendon properties than resistance training alone? - Does resistance training with hydrolyzed collagen ingestion lead to greater changes in muscle size than resistance training alone? Participants will be randomly assigned to collagen or placebo groups. Participants will perform resistance training three times per week for 10 weeks and hydrolyzed collagen or maltodextrin will be given to collagen or placebo group respectively immediately before each resistance training session. Also, vitamin C will be given to both groups. Researchers will compare collagen and placebo groups to see if hydrolyzed collagen ingestion with resistance exercise would have beneficial effects on changes in muscle and tendon more than resistance training alone. Therefore, using isokinetic dynamometer and ultrasonography, maximal leg strength, morphological, mechanical, and material properties of the patellar tendon and vastus lateralis muscle size and architecture will be assessed.
Status | Completed |
Enrollment | 23 |
Est. completion date | March 31, 2023 |
Est. primary completion date | September 29, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 39 Years |
Eligibility | Inclusion Criteria: - Healthy young male or female - No history of patellar tendon injuries in the past 6 months - No history of lower limb musculoskeletal injuries in the past 6 months - Non-smokers (including e-cigarettes) - Free from cardiovascular and metabolic diseases - Nullipara (a woman who has never given birth) Exclusion Criteria: - Age less than 18 years or higher than 40 years - Being vegan or vegetarian (due to the mammalian source of collagen) - Consumption of nutritional supplementation that purportedly affects muscle-tendon adaptation or recovery (i.e. protein powder, vitamin C, collagen) - BMI over 30 kg/m2 - Previous anterior cruciate ligament injury where the patellar tendon was used as a graft |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Research Institute for Sport and Exercise Sciences | Liverpool | Merseyside |
Lead Sponsor | Collaborator |
---|---|
Liverpool John Moores University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maximal knee extensor (quadriceps) muscle strength | Using isokinetic dynamometer, knee extensor maximal isometric voluntary contraction torque (in Newton meters) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for assessments) | |
Primary | Maximal knee flexor (hamstring) muscle strength | Using an isokinetic dynamometer, knee flexor maximal isometric voluntary contraction torque (in Newton meters) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) | |
Primary | Patellar tendon cross-sectional area | Using ultrasonography, patellar tendon cross-sectional area (in millimeters squared) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) | |
Primary | Patellar tendon stiffness | Using ultrasonography, patellar tendon stiffness (in Newtons per millimeter) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) | |
Primary | Vastus lateralis (VL) muscle size | Using ultrasonography, the VL anatomical cross-sectional area (in centimeters squared) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) | |
Primary | Vastus lateralis (VL) muscle fascicle length | Using ultrasonography, VL muscle fascicle length (in millimeters) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) | |
Primary | Vastus lateralis (VL) muscle fascicle pennation angle | Using ultrasonography, VL muscle fascicle pennation angle (in degrees) will be measured. | 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05445440 -
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
|
Phase 1 | |
Completed |
NCT03712540 -
An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
|
Phase 1 | |
Completed |
NCT03649165 -
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT05956002 -
A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants
|
Phase 1 | |
Completed |
NCT05539976 -
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
|
||
Withdrawn |
NCT04558216 -
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
|
Phase 1 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT06097390 -
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
|
Phase 1 | |
Completed |
NCT05546151 -
A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent
|
Phase 1 | |
Completed |
NCT05056246 -
Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants
|
Phase 1 | |
Completed |
NCT04390776 -
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
|
Phase 1 | |
Completed |
NCT05074459 -
A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
|
Phase 1 | |
Enrolling by invitation |
NCT06089109 -
Creating VIP Corps to Reduce Maternal Deaths
|
N/A | |
Completed |
NCT05996250 -
Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
|
N/A | |
Completed |
NCT03278080 -
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1
|
N/A | |
Completed |
NCT05064800 -
PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT04471298 -
A Study of Qishenyiqi Dripping Pills in Healthy Participants
|
Phase 1 | |
Completed |
NCT04914936 -
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
|
Phase 1 | |
Completed |
NCT01681186 -
A Study of LY2940680 in Healthy Participants
|
Phase 1 | |
Completed |
NCT02882386 -
Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements
|
N/A |